Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,874.00    0.00 (0.00%)
Bid:
3,474.00
Ask:
4,156.00
Spread: 682.00 (19.632%)
Market Cap: £14.63b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

17 Dec 2010 07:00

RNS Number : 1449Y
Halma PLC
17 December 2010
 



Halma p.l.c. ('Halma')

 

ACQUISITION OF ACCUDYNAMICS, INC

 

 

Halma, the leading safety, health and sensor technology group, today announces the acquisition of Accudynamics, Inc. ('ADI') on 16 December 2010 for an initial cash consideration of $24.0 million (£15.2 million).

 

ADI is a privately owned business based in Lakeville, Massachusetts, USA and manufactures components primarily for the medical diagnostic system and device markets. Their bespoke products include pumps, fluid handling components and integrated electromechanical assemblies which transport fluids inside their customers' products. ADI will join Halma's Health and Analysis sector within the Fluid Technology group of businesses.

 

Unaudited adjusted accounts for the financial year ended June 2010 show operating profit of $3.7 million (£2.3 million). The initial cash consideration is adjustable $1 for $1 if the completion accounts demonstrate net tangible assets above or below $3.6m (£2.3m). A further $7 million (£4.4 million) is payable based on earnings growth for the period 1 July 2010 to 31 March 2011. The acquisition, which is immediately earnings enhancing, has been funded from Halma's existing cash and debt facilities.

 

Andrew Williams, Halma's Chief Executive, commented:

"ADI is a logical extension of our Fluid Technology sub-sector, enabling us to offer OEM customers integrated sub-assemblies incorporating components from different Halma companies. Following our recent acquisition of Alicat Scientific in November, we have a strong offering for customers requiring precision fluid control in the scientific and medical diagnostic market segments."

 

 

For further information please contact:

 

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

1.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com.

2.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

3.

Exchange rate used: $1.58/£1.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTFBRTMBABBMM
Date   Source Headline
9th Sep 20054:41 pmRNSHolding(s) in Company
2nd Sep 20057:00 amRNSAdoption of IFRS
12th Aug 20059:32 amRNSDirector/PDMR Shareholding
11th Aug 20059:15 amRNSAcquisition
10th Aug 20053:23 pmRNSDirector/PDMR Shareholding
9th Aug 20052:30 pmRNSDirector/PDMR Shareholding
5th Aug 200512:44 pmRNSResult of AGM
3rd Aug 20057:00 amRNSAGM Statement
29th Jul 20054:53 pmRNSBlocklisting Interim Review
27th Jul 200511:11 amRNSHolding(s) in Company
22nd Jul 20054:05 pmRNSAnnual Information Update
19th Jul 20051:24 pmRNSAcquisition
12th Jul 20054:16 pmRNSDirector/PDMR Shareholding
12th Jul 20052:55 pmRNSHolding(s) in Company
6th Jul 20054:37 pmRNSDirector/PDMR Shareholding
5th Jul 20055:16 pmRNSAnnual Report and Accounts
1st Jul 20054:45 pmRNSHolding(s) in Company
29th Jun 20059:56 amRNSDirector Shareholding
24th Jun 20054:53 pmRNSDirector Shareholding
21st Jun 20057:00 amRNSFinal Results
6th Jun 20059:51 amRNSNotice of Board Meeting
28th Apr 20057:00 amRNSTrading Statement
1st Mar 20057:00 amRNSDirectorate Change
8th Feb 200510:15 amRNSDirector Shareholding
17th Jan 20059:30 amRNSBlocklisting Interim Review
17th Jan 20059:26 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.